Collateral sensitivity to the bisdioxopiperazine dexrazoxane (ICRF-187) in etoposide (VP-16)-resistant human leukemia K562 cells.
about
Implementation of high-content assay for inhibitors of mitogen-activated protein kinase phosphatases.Simultaneous quantitation of topoisomerase II alpha and beta isoform mRNAs in lung tumor cells and normal and malignant lung tissue.The anticancer multi-kinase inhibitor dovitinib also targets topoisomerase I and topoisomerase II.Structure-based design, synthesis and biological testing of etoposide analog epipodophyllotoxin-N-mustard hybrid compounds designed to covalently bind to topoisomerase II and DNAStructure-based design, synthesis and biological testing of piperazine-linked bis-epipodophyllotoxin etoposide analogsDexrazoxane ameliorates doxorubicin-induced injury in mouse ovarian cells.Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).Mechanisms of Action and Reduced Cardiotoxicity of Pixantrone; a Topoisomerase II Targeting Agent with Cellular Selectivity for the Topoisomerase IIα Isoform.Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies.The structure-based design, synthesis and biological evaluation of DNA-binding bisintercalating bisanthrapyrazole anticancer compounds.Design, synthesis, and biological evaluation of a novel series of bisintercalating DNA-binding piperazine-linked bisanthrapyrazole compounds as anticancer agents.The anticancer thiosemicarbazones Dp44mT and triapine lack inhibitory effects as catalytic inhibitors or poisons of DNA topoisomerase IIα.Design, synthesis and biological evaluation of a novel series of anthrapyrazoles linked with netropsin-like oligopyrrole carboxamides as anticancer agentsCadmium is a catalytic inhibitor of DNA topoisomerase II.Acute dosage with dexrazoxane, but not doxorubicin, is associated with increased rates of hepatic protein synthesis in vivo.
P2860
Q33285971-A1496D1B-7A30-4224-ADF1-45B20EAA16B0Q33908149-FFBD39B7-DC09-484D-98F1-1CB319E8099BQ34435367-E69C5792-C968-4433-8FD0-1F50AD12B1DFQ34623523-AB44CE9B-7E00-47D6-A9C8-90D928BFC276Q35706214-07D7DCBB-88BE-4812-98BE-0D06D71C7779Q35862550-296D211B-215C-4814-A521-D148FDBC302DQ36021497-1DE6ABF2-0653-4D69-92BD-1A3B12D95176Q36559677-E38D6937-A72E-4BF0-96A5-72152F86F801Q37010772-18C7E885-824E-40D8-A2C1-5A6118535F84Q38952371-80C13416-0739-47C8-BA11-9AC1F09DD26AQ39016546-69324D66-C291-445D-B1A4-7926404E8A51Q39364743-4491AE03-D0F2-4CFC-AEDD-524AC9F52CD3Q40866754-8038F1E6-310E-4C13-971B-B25A0E214757Q42731428-1C694104-CF71-4083-A253-C585A95AB6C9Q43856596-007626B5-9408-4F42-8748-8EDD6F0203A0
P2860
Collateral sensitivity to the bisdioxopiperazine dexrazoxane (ICRF-187) in etoposide (VP-16)-resistant human leukemia K562 cells.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Collateral sensitivity to the ...... ant human leukemia K562 cells.
@en
type
label
Collateral sensitivity to the ...... ant human leukemia K562 cells.
@en
prefLabel
Collateral sensitivity to the ...... ant human leukemia K562 cells.
@en
P2093
P1476
Collateral sensitivity to the ...... ant human leukemia K562 cells.
@en
P2093
Fattman CL
Hasinoff BB
Yalowich JC
P304
P356
10.1016/0006-2952(96)00338-3
P407
P577
1996-08-01T00:00:00Z